Companies: 10,795·Total market cap: $144.5T
Bausch + Lomb Corporation

Bausch + Lomb Corporation

BLCO.TOTSXHealthcare● Active
$21.18
$-0.46(-2.13%)
Market Cap$7.6B
P/E Ratio
52W High$25.7
52W Low$15.69

Bausch + Lomb Corporation (BLCO.TO) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

BLCO.TO · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
353.8M +0.54% YoY Change
FY · as of Dec 31, 2025 · Reported in USD
vs 351.9M in FY 2024
Diluted Shares Outstanding
353.8M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+0.54%
year-over-year
Float (Free Float)
37.8M
publicly tradable shares
10.6% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+0.4%
2022 → 2025
5-Year CAGRincreasing
+0.2%
2020 → 2025
10-Year CAGR

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 353.8M
353.8M
+0.54%
FY 2024
Diluted Shares: 353.9M
351.9M
+0.40%
FY 2023
Diluted Shares: 350.5M
350.5M
+0.14%
FY 2022
Diluted Shares: 350.2M
350.0M
+0.00%
FY 2021
Diluted Shares: 350.0M
350.0M
+0.00%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs BLCO.TO
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+607.2%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+586.4%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+403.2%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+338.1%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+157.2%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+153.8%
#7
Bausch + Lomb CorporationBLCO.TO
Bausch + Lomb CorporationYOU
353.8M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Bausch + Lomb Corporation (BLCO.TO) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, Bausch + Lomb Corporation reports 353.8M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Bausch + Lomb Corporation's basic shares outstanding (353.8M) represents currently issued shares. Diluted shares outstanding (353.8M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Bausch + Lomb Corporation's float is 37.8M (10.6% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float37.8M(10.6%)
Outstanding356.5M

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Bausch + Lomb Corporation (BLCO.TO) shares outstanding history from 2018 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Bausch + Lomb Corporation shares outstanding for the fiscal year ending December 31, 2025 were 353.8M, a 0.54% increase year-over-year. Bausch + Lomb Corporation FY 2025 shares outstanding were 353.8M, a +0.54% increase from FY 2024.

Bausch + Lomb Corporation is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

BLCO.TO shares outstanding · 4 questions

As of December 31, 2025, Bausch + Lomb Corporation (BLCO.TO) has approximately 353.8M basic shares outstanding and 353.8M diluted shares outstanding. This represents a +0.54% year-over-year increase from FY 2024 (351.9M). The increase may reflect equity compensation issuances or secondary offerings.

BLCO.TO shares outstandinghow many shares does BLCO.TO haveBLCO.TO basic shares 2025BLCO.TO diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Bausch + Lomb Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08